Literature DB >> 15701109

Drug-use pattern, comorbid psychosis and mortality in people with a history of opioid addiction.

H J Sørensen1, P W Jepsen, S Haastrup, K Juel.   

Abstract

OBJECTIVE: To compare the 15-year mortality of people with a history of opioid dependence that had achieved stable abstinence, with the mortality associated with continued drug use. Another objective was to study the influence of hospitalization with comorbid psychosis on the 15-year mortality.
METHOD: In 1984, 188 persons (122 men and 66 women) with a history of intravenous narcotics addiction were interviewed about their drug-use pattern. A registry-based follow-up continued through 1999 and mortality was assessed. Three 1984-drug-use categories were formed. In category 1, cohort members had achieved stable abstinence from drug use by 1984. Using Cox multiple regression analysis, we (i) estimated reduced mortality of category 1 drug users, and (ii) studied the influence of hospitalization with comorbid psychosis on mortality.
RESULTS: About 32% had died during the 15-year follow-up. The 15-year mortality associated with stable abstinence was reduced by 56% when compared with the perceived worst drug-use pattern. Hospitalization for comorbid psychosis was not independently associated with mortality in this sample. When drug-use categories were compared with mortality expectations for the general population, the standard mortality rates (SMRs) were clearly elevated. Even in the stably abstinent drug-use category (category 1), SMR was significantly elevated by at least seven-fold in both genders.
CONCLUSION: People who had achieved stable abstinence from injecting narcotics use were at lower risk of premature death than people with continued drug use. A residual observed excess mortality in people who had apparently achieved stable abstinence from drug use is consistent with the view of drug addiction as a chronic disease. Copyright (c) Blackwell Munksgaard 2004

Entities:  

Mesh:

Year:  2005        PMID: 15701109     DOI: 10.1111/j.1600-0447.2004.00445.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  10 in total

1.  Years of potential life lost among heroin addicts 33 years after treatment.

Authors:  Breda Smyth; Valerie Hoffman; Jing Fan; Yih-Ing Hser
Journal:  Prev Med       Date:  2007-02-08       Impact factor: 4.018

Review 2.  Mortality among people who inject drugs: a systematic review and meta-analysis.

Authors:  Bradley M Mathers; Louisa Degenhardt; Chiara Bucello; James Lemon; Lucas Wiessing; Mathew Hickman
Journal:  Bull World Health Organ       Date:  2013-02-01       Impact factor: 9.408

3.  Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers: a prospective longitudinal study 1970-2006.

Authors:  Anna Nyhlén; Mats Fridell; Martin Bäckström; Morten Hesse; Peter Krantz
Journal:  BMC Psychiatry       Date:  2011-07-30       Impact factor: 3.630

4.  Buprenorphine maintenance program with contracted work/education and low tolerance for non-prescribed drug use: a cohort study of outcome for women and men after seven years.

Authors:  Leif Öhlin; Mats Fridell; Anna Nyhlén
Journal:  BMC Psychiatry       Date:  2015-03-24       Impact factor: 3.630

5.  Total and cause-specific standardized mortality ratios in patients with schizophrenia and/or substance use disorder.

Authors:  Ina H Heiberg; Bjarne K Jacobsen; Ragnar Nesvåg; Jørgen G Bramness; Ted Reichborn-Kjennerud; Øyvind Næss; Eivind Ystrom; Christina M Hultman; Anne Høye
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

6.  Comorbid opioid use is undertreated among forensic patients with schizophrenia.

Authors:  Kristiina Kivimies; Eila Repo-Tiihonen; Hannu Kautiainen; Jari Tiihonen
Journal:  Subst Abuse Treat Prev Policy       Date:  2018-11-06

7.  Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up.

Authors:  Mats Fridell; Martin Bäckström; Morten Hesse; Peter Krantz; Sean Perrin; Anna Nyhlén
Journal:  BMC Psychiatry       Date:  2019-05-15       Impact factor: 3.630

8.  A 20-year prospective study of mortality and causes of death among hospitalized opioid addicts in Oslo.

Authors:  Mari A Bjornaas; Anette S Bekken; Aasa Ojlert; Tor Haldorsen; Dag Jacobsen; Morten Rostrup; Oivind Ekeberg
Journal:  BMC Psychiatry       Date:  2008-02-13       Impact factor: 3.630

9.  Five-year mortality after acute poisoning treated in ambulances, an emergency outpatient clinic and hospitals in Oslo.

Authors:  Cathrine Lund; Mari A Bjornaas; Leiv Sandvik; Oivind Ekeberg; Dag Jacobsen; Knut E Hovda
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2013-08-21       Impact factor: 2.953

10.  A Meta-Analysis of the Efficacy of Case Management for Substance Use Disorders: A Recovery Perspective.

Authors:  Wouter Vanderplasschen; Richard C Rapp; Jessica De Maeyer; Wim Van Den Noortgate
Journal:  Front Psychiatry       Date:  2019-04-16       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.